BRD4 and neuroblastoma: Moreover, the combined application of BRD4 inhibitor I-BET151 and AURKA inhibitor alisertib significantly inhibited the neuroblastoma cells growth and dramatically prolonged the survival time of neuroblastoma xenograft mice (Felgenhauer et al., 2018).